Menu
We started business abroad with continuous growth and managed to obtain product qualification certificates in Japan, USA, China, Canada, Russia, and other countries. We continue to expand and currently export to more than 79 countries.
As a leading medical company, we manufacture a vast range of medical equipment with our own unique designs; mainly gastrointestinal medical metallic stents, urology stents, RFA treatment and a variety of accessories.
Our objective is to maintain high levels of innovation, knowledge, and technical expertise to provide solutions for patient’s comfort. In addition, we are continuously expanding into new businesses and high-growth adjacent markets to reach out to more patients around the world.
We will always continue to deliver our values and invest our passion for the greater benefit of all patients.
Observing the need in the patient community for a new stent design that provides more comfort, TaeWoong Medical Co., Ltd. was founded in 1991.
Within 8 years, TaeWoong Medical Co., Ltd. has established itself as an incorporated company, qualified as a manufacturer of medical devices and permitted to manufacture medical apparatus and Niti-S™ Stents.
In 2000, TaeWoong Medical was selected as a venture company for excellent technology development from various organizations and acquired CE certification of Niti-S™ COMVI, embarking on a new journey of expansion around the globe.
Significant change during the global pandemic has stress-tested many organizations, including ours, both on the principles underpinning corporate sustainability and our execution in a time of deep uncertainty. This period has highlighted reliance on our deeply held corporate values, robust operating processes, and enduring commitment to customers, employees, and communities.
In our earliest days, we built a framework to articulate the value we bring to the multiple stakeholders we serve, from customers to employees, suppliers, our communities and our shareholders. This forms the foundation of our culture and informs our decision-making, priorities, and actions.
Disclosures & Important Safety Information
Patients should talk to their doctor to decide if any TaeWoong Medical USA procedure is right for them. Patients and doctors should review all available information on non-surgical and surgical options and associated risks in order to make an informed decision.
Serious complications may occur in any surgery, including death. Serious risks include, but are not limited to, injury to tissues and organs and conversion to other surgical techniques which could result in a longer operative time and/or increased complications. For Important Safety Information, including surgical risks, indications, and considerations and contraindications for use.
Individuals’ outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience.
